Antibacterial Envelope of Cardiac Implantable Device

Antibacterial Envelope to Prevent Cardiac Implantable Device Infection
Adjunctive use of an antibacterial envelope resulted in a significantly lower incidence of major CIED infections than standard-of-care infection-prevention strategies alone, without a higher incidence of complications. (Funded by Medtronic; WRAP-IT ClinicalTrials.gov number, NCT02277990.)
Author(s) Source
Tarakij KG et al. The New England Journal of Medicine, March 17, 2019
DOI: 10.1056/NEJMoa1901111
This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register.
Comments: n/a
let us know

COVID-19
news

stay connected

don’t miss any news of the
Implant-Register,
tailored to your preferences

                                  GET IT!

Scroll to Top